The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Phase I study of ABT-700, an anti-c-Met antibody, in patients (pts) with advanced gastric or esophageal cancer (GEC).
 
Yoon-Koo Kang
No Relationships to Disclose
 
Patricia LoRusso
No Relationships to Disclose
 
Ravi Salgia
No Relationships to Disclose
 
Chia-Jui Yen
No Relationships to Disclose
 
Chia-Chi Lin
No Relationships to Disclose
 
Ramesh K. Ramanathan
Honoraria - See under advisory Boards
Consulting or Advisory Role - Caris Life Sciences; Celgene; Genentech; Immunomedics; Lilly; Sanofi; Sanofi; Taiho Pharmaceutical; Vaccinex
Speakers' Bureau - Celgene
Research Funding - Abbvie; AVEO; Bayer; Biomarin; Celgene; Dekkun Corporation; Endocyte; Genentech; Halozyme; Merck/Schering Plough; Merrimack; Sanofi; Tekmira; Vaccinex; Verastem
Travel, Accommodations, Expenses - Biomarin
 
Patrick Kaminker
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Irina Sokolova
Employment - Abbott Laboratories
Stock and Other Ownership Interests - Abbott Laboratories
 
Anahita Bhathena
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Lan Wang
No Relationships to Disclose
 
Louie Naumovski
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
John H. Strickler
Consulting or Advisory Role - Amgen; Bayer/Onyx; Marval Biosciences
Research Funding - Abbvie (Inst); ArQule (Inst); Bayer (Inst); Eisai (Inst); Exelixis (Inst); Gilead Sciences (Inst); Lilly (Inst); MethylGene (Inst); OncoMed (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst)